NVIV logo

InVivo Therapeutics Holdings Corp


NVIV: InVivo Therapeutics Holdings Corp is a research and clinical stage biomaterials and biotechnology company. It focuses on the treatment of spinal cord injury. The company's product pipeline consists of Neuro spinal scaffold and Bioengineered neural trails. The firm has a clinical development program for acute spinal cord injury and a preclinical development program for chronic spinal cord injury.


Show NVIV Financials

Consumer Interest
SEC Filings

Recent trades of NVIV by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quiver Logo

No Whale Activity for this ticker

Institutional Holdings Dashboard

Quarterly net insider trading by NVIV's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Poly((lactic-co-glycolic acid)-b-lysine) and process for synthesizing a block copolymer of plga {poly(lactic-co-glycolic acid)} and pll (poly-ϵ-cbz-l-lysine) Nov. 20, 2018
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of NVIV in WallStreetBets Daily Discussion


Recent insights relating to NVIV

CNBC Recommendations

Recent picks made for NVIV stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in NVIV

Corporate Flights

Flights by private jets registered to NVIV